Catalina Pulecio Doctor of Pharmacy Candidate, College of Pharmacy, Western University of Health Sciences, Pomona, California   Nutrigenomics is a fast-moving field of research that combines molecular biology, genetics and nutrition to regulate gene expression through specific nutrients.1

Introducing 3 mL of Humulin N in a Smaller Vial Lilly introduces smaller vials containing 3 mL of insulin in a 5 mL vial. The smaller vials are designed to give hospitals flexibility when evaluating insulin storage and distribution (floor stock vs individual patient supply). Same bar-coding technique, same color-differentiating …

Why Some Obese People Go On to Become Diabetic While Others Do Not: It is common to find obese people (even morbidly obese people) who are healthier than their condition would normally allow. Working with subjects with a BMI of about 56, a team of researchers investigated the inflammatory and …

People with Diabetes Guaranteed Health Insurance: This rule comes under the new Patient Protection and Affordable Care Act. The rules will help simplify the denial process and create consistency in all 50 states. “In order to stay healthy, people with diabetes have to manage their disease with supplies like test …

Alcohol Consumption and Retinopathy — Visual Acuity: The association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes was studied. In a cohort analysis of 1,239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of …

FDA Approves a 3-in-1 Combination Hypertension Drug: The drug Tribenzor is approved as a once-daily treatment for hypertension which combines olmesartan medoxomil, amlodipine, and hydrochlorothiazide in a single tablet. Tribenzor is approved for patients who are not adequately controlled on any two of the following antihypertensive drug classes: angiotensin receptor …

With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks….

American bioengineers have demonstrated that an implanted glucose sensor with potential to transform the management of diabetes has passed a crucial test: the device they developed worked continuously for over a year, without showing signs of “tissue encapsulation” seen in trials with other similar devices...

Number of births increases the risk of developing gestational diabetes in pregnant women with a history of the condition, a new study has revealed…

A London company may be on the verge of a groundbreaking treatment for diabetes. A mini pancreas pouch could begin human clinical trials within a year….